Germany’s Drug‑Price Move and the U. S. Push for Fair Share
The United States spends a huge portion of the money that fuels new medicines, from cancer drugs to treatments for rare diseases. Because American companies invest most of the research and development money, they earn a lot of the profits that cover these costs. European governments often negotia